Alpine Partners VI »

Enliven Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $262k 11k 23.37

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics